Literature DB >> 23650013

When is protein binding important?

Jules Heuberger1, Stephan Schmidt, Hartmut Derendorf.   

Abstract

The present paper is an ode to a classic citation by Benet and Hoener (2002. Clin Pharm Ther 71(3):115-121). The now classic paper had a huge impact on drug development and the way the issue of protein binding is perceived and interpreted. Although the authors very clearly pointed out the limitations and underlying assumptions for their delineations, these are too often overlooked and the classic paper's message is misinterpreted by broadening to cases that were not intended. Some members of the scientific community concluded from the paper that protein binding is not important. This was clearly not intended by the authors, as they finished their paper with a paragraph entitled: "When is protein binding important?" Misinterpretation of the underlying assumptions in the classic work can result in major pitfalls in drug development. Therefore, we revisit the topic of protein binding with the intention of clarifying when clinically relevant changes should be considered during drug development.
Copyright © 2013 Wiley Periodicals, Inc.

Keywords:  drug interaction; in vitro models; in vitro/in vivo correlations (IVIVC); microdialysis; pharmacokinetics; protein binding

Mesh:

Substances:

Year:  2013        PMID: 23650013     DOI: 10.1002/jps.23559

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  18 in total

Review 1.  Nonlinear Protein Binding: Not What You Think.

Authors:  Amelia N Deitchman; Ravi Shankar Prasad Singh; Hartmut Derendorf
Journal:  J Pharm Sci       Date:  2018-04-04       Impact factor: 3.534

2.  Interethnic scaling of fraction unbound of a drug in plasma and volume of distribution: an analysis of extrapolation from Caucasians to Chinese.

Authors:  Guo Yu; Hong-Hao Zhou; Qing-Shan Zheng; Guo-Fu Li
Journal:  Eur J Clin Pharmacol       Date:  2018-12-19       Impact factor: 2.953

Review 3.  Biological barriers, and the influence of protein binding on the passage of drugs across them.

Authors:  Karolina Wanat
Journal:  Mol Biol Rep       Date:  2020-03-05       Impact factor: 2.316

4.  Protein binding characteristics and pharmacokinetics of ceftriaxone in intensive care unit patients.

Authors:  Michael Schleibinger; Cathérine L Steinbach; Christoph Töpper; Alexander Kratzer; Uwe Liebchen; Frieder Kees; Bernd Salzberger; Martin G Kees
Journal:  Br J Clin Pharmacol       Date:  2015-06-11       Impact factor: 4.335

5.  Pharmacokinetics of the novel oral prostacyclin receptor agonist selexipag in subjects with hepatic or renal impairment.

Authors:  Priska Kaufmann; Hans G Cruz; Andreas Krause; Ivan Ulč; Atef Halabi; Jasper Dingemanse
Journal:  Br J Clin Pharmacol       Date:  2016-05-10       Impact factor: 4.335

6.  Brief Report: Significant Decreases in Both Total and Unbound Lopinavir and Amprenavir Exposures During Coadministration: ACTG Protocol A5143/A5147s Results.

Authors:  Julie B Dumond; Joseph Rigdon; Katie Mollan; Camlin Tierney; Angela D M Kashuba; Francesca Aweeka; Ann C Collier
Journal:  J Acquir Immune Defic Syndr       Date:  2015-12-15       Impact factor: 3.731

7.  Evaluation of Quantitative Structure Property Relationship Algorithms for Predicting Plasma Protein Binding in Humans.

Authors:  Yejin Esther Yun; Rogelio Tornero-Velez; S Thomas Purucker; Daniel T Chang; Andrea N Edginton
Journal:  Comput Toxicol       Date:  2021-02-01

8.  A Phase II Randomized Trial to Explore the Potential for Pharmacokinetic Drug-Drug Interactions with Stiripentol or Valproate when Combined with Cannabidiol in Patients with Epilepsy.

Authors:  Elinor Ben-Menachem; Boudewijn Gunning; Carmen María Arenas Cabrera; Kevan VanLandingham; Julie Crockett; David Critchley; Louise Wray; Bola Tayo; Gilmour Morrison; Manuel Toledo
Journal:  CNS Drugs       Date:  2020-06       Impact factor: 5.749

9.  Canine orosomucoid (alpha-1 acid glycoprotein) variants and their influence on drug plasma protein binding.

Authors:  Ana P Costa; Michael H Court; Nicolas F Villarino; Neal S Burke; Katrina L Mealey
Journal:  J Vet Pharmacol Ther       Date:  2020-08-03       Impact factor: 1.786

10.  Liquid chromatography-tandem mass spectrometry for the simultaneous quantitation of ceftriaxone, metronidazole and hydroxymetronidazole in plasma from seriously ill, severely malnourished children.

Authors:  Martin Ongas; Joseph Standing; Bernhards Ogutu; Joseph Waichungo; James A Berkley; Karin Kipper
Journal:  Wellcome Open Res       Date:  2017-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.